Cervical Cancer is the second most common cancer among women worldwide, with approximately 440,000 new cases reported annually. Certain types of Human papillomavirus (HPV) cause cervical cancer.

Testing for HPV is a far more accurate way to detect cancer and pre-cancer than the current management strategy of repeating the Pap smear following a borderline or mildly abnormal Pap result.

Digene's Hybrid Capture 2® HPV DNA Test detects this virus in cervical samples. Diagnostic Technology in conjunction with Digene is committed to educating healthcare providers, patients and laboratory technicians about cervical cancer, HPV and the role of Hybrid Capture® technology in patient care.

For information on Herpes go to What is Herpes?

For more information on Digene's HPV DNA Testing go to Cervical Cancer.

For more information on Cervical Cancer and HPV Testing go to www.thehpvtest.com.

LATEST PRESS RELEASES

For a copy of key publications, literature, or to
answer any questions about HPV DNA testing please
call Diagnostic Technology on 1800 803 950, or e-mail us at
info@diagnostictechnology.com.au